Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00410514Phase 2Completed
A Phase 2 trial of mirabegron in lower urinary tract symptoms (LUTS), sponsored by Astellas Pharma. Started Dec 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00410514.